<DOC>
	<DOCNO>NCT00406991</DOCNO>
	<brief_summary>The project aim find mechanisms abnormal retinal blood flow diabetic patient often precede evidence clinical retinopathy may contribute development retinopathy . Specifically , project test hypothesis reduce retinal blood flow find young patient type 1 diabetes reflect increased resistance small vessel retina cause formation small blood clot , call microthrombi ; antiplatelet agent normalize reduce retinal blood flow .</brief_summary>
	<brief_title>Retinal Blood Flow Microthrombi Type 1 Diabetes</brief_title>
	<detailed_description>The ultimate goal research contribute development strategy prevent diabetic retinopathy . This project test hypothesis antiplatelet agent normalize reduce blood flow observe early course type 1 diabetes . If hypothesis proven correct , result indicate formation small blood clot ( microthrombi ) occur early diabetic retinal vessel . In turn , microthrombosis could readily account occlusive microangiopathy cause sight-threatening stage diabetic retinopathy , result propose desirability antiplatelet therapy prevention diabetic retinopathy . We three specific aim : 1 . To confirm , basal condition , retinal blood flow measure laser Doppler method group type 1 diabetic patient minimal retinopathy differs flow measure age- sex-matched nondiabetic control subject ; 2 . To determine whether response retinal blood flow low-dose aspirin ( 81 mg/day ) administer 2 month versus placebo , differs type 1 diabetic patient minimal retinopathy age- sex-matched nondiabetic control subject ; 3 . To determine whether type 1 diabetic patient minimal retinopathy response retinal blood flow low-dose aspirin differs response clopidogrel , drug interferes platelet function downstream site aspirin action .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Age 1845 year , type 1 diabetes duration 115 year , absent minimal retinopathy ( EDTRS 20 ) . Age gendermatched healthy control smoke , systemic disease diabetes , retinal disease diabetic retinopathy , pregnancy , bleed disorder , aspirin allergy , use antiplatelet agent , nonsteroidal antiinflammatory agent , angiotensin convert enzyme inhibitor , angiotensin receptor antagonist , Vitamin E large dos .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>retinal blood flow</keyword>
	<keyword>diabetic retinopathy</keyword>
	<keyword>microthrombosis</keyword>
	<keyword>aspirin</keyword>
	<keyword>clopidogrel</keyword>
</DOC>